Incidence of myelodysplastic syndromes in Finland 1997-2016.
Sign Up to like & getrecommendations! Published in 2022 at "Leukemia research"
DOI: 10.1016/j.leukres.2022.106839
Abstract: Myelodysplastic syndromes (MDS) are a diverse group of clonal hematopoietic stem cell diseases that may progress to acute myeloid leukemia. Here, we present incidence of myelodysplastic syndromes based on a nationwide, registry-based study. A total… read more here.
Keywords: incidence; incidence myelodysplastic; myelodysplastic syndromes; trend ... See more keywords
Incidence of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients (pts) with a germline (g) BRCA mutation (m) and platinum-sensitive relapsed ovarian cancer (PSR OC) receiving maintenance olaparib in SOLO2: Impact of prior lines of platinum therapy.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.5548
Abstract: 5548Background: Olaparib has been investigated and subsequently approved as maintenance treatment after response to platinum-based chemotherapy in pts with relapsed OC. A relationship between incre... read more here.
Keywords: syndrome mds; platinum; maintenance; myelodysplastic syndrome ... See more keywords